Assessment of an Oral Endotracheal Subglottic Tube Holder

July 2, 2019 updated by: Hollister Incorporated

Assessment of AnchorFast Guard Subglottic ET (Endotracheal) Tube

This study is designed to assess the acceptability and usability of a new Endotracheal Tube (ET) holding device for an orally intubated patient.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a multiple site prospective assessment of the study product in ICU settings. The study is comprised of each intubated subject wearing one study product until the device either needs to be changed or is no longer required by the subject. The study product is designed to hold a standard or subglottic ET tube and help reduce the potential for occlusion (blockage) of the tube.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Fresno, California, United States, 93701
        • Community Regional Medical Center
    • Oregon
      • Gresham, Oregon, United States, 97030
        • Legacy Mount Hood Medical Center
      • Portland, Oregon, United States, 97210
        • Legacy Good Samaritan Medical Center
      • Portland, Oregon, United States, 97227
        • Legacy Emanuel Hospital & Health Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

INCLUSION CRITERIA

  1. Is 18 years of age or older and require oral tracheal intubation with subglottic ET tube size 6.0-8.0mm
  2. Requires the use of a bite block per the hospital's standard of care
  3. Has intact skin on and around application site, including cheeks and lips
  4. Oral cavity is free of open sores, ulcers, wounds, and lesions
  5. Subject or Legal Authorized representative (LAR) able to provide informed consent for the study
  6. Is qualified to participate in the opinion of the Investigator, or designee

EXCLUSION CRITERIA

  1. Has actual or perceived loose teeth, is without teeth, or is unable to wear upper dentures
  2. Has facial hair that interferes with the adhesion of the skin barrier pads
  3. Has a clinically significant skin disease or condition, or damaged skin on the application site, such as psoriasis, eczema, atopic dermatitis, active cancer, sores, sunburns, scars, moles
  4. Has a medical condition, surgery or a procedure that prevents the proper application of the device, including placement of the neck strap.
  5. Has a known or stated allergy to adhesives
  6. Currently is participating in any clinical study which may affect the performance of the device

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: New oral endotracheal tube holder
Single Study Product Arm
The single arm study product is designed to hold a standard or subglottic ET tube.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Acceptability With Study Product
Time Frame: At product removal (maximum 29 days of patient wearing product)
The overall acceptability relating to general experience with the study product during use will be rated with a 5-point Likert scale ranging from 1=Very Unacceptable to 5=Very Acceptable
At product removal (maximum 29 days of patient wearing product)
Usability of Study Product
Time Frame: At application and product removal (maximum 29 days of patient wearing product)
The usability of the study product at application and at removal.
At application and product removal (maximum 29 days of patient wearing product)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Vander Werff, MD, Legacy Mount Hood Medical Center
  • Principal Investigator: Brian Young, MD, 1. Legacy Emanuel Hospital & Health Center 2. Legacy Good Samaritan Medical Center
  • Principal Investigator: Arash Afshinnik, MD, Community Regional Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2017

Primary Completion (Actual)

June 8, 2018

Study Completion (Actual)

June 15, 2018

Study Registration Dates

First Submitted

October 16, 2017

First Submitted That Met QC Criteria

October 27, 2017

First Posted (Actual)

November 1, 2017

Study Record Updates

Last Update Posted (Actual)

July 5, 2019

Last Update Submitted That Met QC Criteria

July 2, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 5855-I

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation

Clinical Trials on New oral endotracheal tube holder

3
Subscribe